HAS2 and breast carcinoma: Importantly, the upregulation of HAS2 in highly metastatic breast cancer stem-like cells showed its critical role for the interaction of the cells with TAMs, leading to enhanced secretion of platelet-derived growth factor-BB from TAMs, which then activated stromal cells and enhanced the breast cancer stem-like cells self-renewal [86].